BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 10924951)

  • 1. Complex motor disturbances in a sequential double lesion rat model of striatonigral degeneration (multiple system atrophy).
    Scherfler C; Puschban Z; Ghorayeb I; Goebel GP; Tison F; Jellinger K; Poewe W; Wenning GK
    Neuroscience; 2000; 99(1):43-54. PubMed ID: 10924951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoradiographic study of striatal dopamine re-uptake sites and dopamine D1 and D2 receptors in a 6-hydroxydopamine and quinolinic acid double-lesion rat model of striatonigral degeneration (multiple system atrophy) and effects of embryonic ventral mesencephalic, striatal or co-grafts.
    Puschban Z; Scherfler C; Granata R; Laboyrie P; Quinn NP; Jenner P; Poewe W; Wenning GK
    Neuroscience; 2000; 95(2):377-88. PubMed ID: 10658617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 'single toxin-double lesion' rat model of striatonigral degeneration by intrastriatal 1-methyl-4-phenylpyridinium ion injection: a motor behavioural analysis.
    Ghorayeb I; Fernagut PO; Hervier L; Labattu B; Bioulac B; Tison F
    Neuroscience; 2002; 115(2):533-46. PubMed ID: 12421620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of a multiple system atrophy model in rats using multitracer microPET.
    Yoon HH; Lee CS; Hong SH; Min J; Kim YH; Hwang O; Jeon SR
    Acta Neurochir (Wien); 2012 May; 154(5):935-40. PubMed ID: 21866326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous intrastriatal 6-hydroxydopamine and quinolinic acid injection: a model of early-stage striatonigral degeneration.
    Ghorayeb I; Puschban Z; Fernagut PO; Scherfler C; Rouland R; Wenning GK; Tison F
    Exp Neurol; 2001 Jan; 167(1):133-47. PubMed ID: 11161601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No functional effects of embryonic neuronal grafts on motor deficits in a 3-nitropropionic acid rat model of advanced striatonigral degeneration (multiple system atrophy).
    Waldner R; Puschban Z; Scherfler C; Seppi K; Jellinger K; Poewe W; Wenning GK
    Neuroscience; 2001; 102(3):581-92. PubMed ID: 11226695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Riluzole improves motor deficits and attenuates loss of striatal neurons in a sequential double lesion rat model of striatonigral degeneration (parkinson variant of multiple system atrophy).
    Scherfler C; Sather T; Diguet E; Stefanova N; Puschban Z; Tison F; Poewe W; Wenning GK
    J Neural Transm (Vienna); 2005 Aug; 112(8):1025-33. PubMed ID: 15583958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Failure of caspase inhibition in the double-lesion rat model of striatonigral degeneration (multiple system atrophy).
    Mantoan L; Stefanova N; Egger KE; Jellinger KA; Poewe W; Wenning GK
    Acta Neuropathol; 2005 Feb; 109(2):191-7. PubMed ID: 15549330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A rat model of striatonigral degeneration generated by simultaneous injection of 6-hydroxydopamine into the medial forebrain bundle and quinolinic acid into the striatum.
    Yoon HH; Kim YH; Shin ES; Jeon SR
    J Korean Med Sci; 2014 Nov; 29(11):1555-61. PubMed ID: 25408589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. L-dopa response pattern in a rat model of mild striatonigral degeneration.
    Kaindlstorfer C; Stefanova N; Garcia J; Krismer F; Döbrössy M; Göbel G; Jellinger K; Granata R; Wenning GK
    PLoS One; 2019; 14(6):e0218130. PubMed ID: 31181111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Failure of neuroprotection by embryonic striatal grafts in a double lesion rat model of striatonigral degeneration (multiple system atrophy).
    Puschban Z; Waldner R; Seppi K; Stefanova N; Humpel C; Scherfler C; Levivier M; Poewe W; Wenning GK
    Exp Neurol; 2000 Jul; 164(1):166-75. PubMed ID: 10877927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Towards neurotransplantation in multiple system atrophy: clinical rationale, pathophysiological basis, and preliminary experimental evidence.
    Wenning GK; Tison F; Scherfler C; Puschban Z; Waldner R; Granata R; Ghorayeb I; Poewe W
    Cell Transplant; 2000; 9(2):279-88. PubMed ID: 10811400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversal of behavioural abnormalities by fetal allografts in a novel rat model of striatonigral degeneration.
    Wenning GK; Granata R; Laboyrie PM; Quinn NP; Jenner P; Marsden CD
    Mov Disord; 1996 Sep; 11(5):522-32. PubMed ID: 8866493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavioral and histological analysis of a partial double-lesion model of parkinson-variant multiple system atrophy.
    Kaindlstorfer C; García J; Winkler C; Wenning GK; Nikkhah G; Döbrössy MD
    J Neurosci Res; 2012 Jun; 90(6):1284-95. PubMed ID: 22488729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of unilateral and bilateral intrastriatal 6-hydroxydopamine-induced axon terminal lesions: evidence for interhemispheric functional coupling of the two nigrostriatal pathways.
    Roedter A; Winkler C; Samii M; Walter GF; Brandis A; Nikkhah G
    J Comp Neurol; 2001 Apr; 432(2):217-29. PubMed ID: 11241387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neonatal hypoxic-ischemic or excitotoxic striatal injury results in a decreased adult number of substantia nigra neurons.
    Burke RE; Macaya A; DeVivo D; Kenyon N; Janec EM
    Neuroscience; 1992 Oct; 50(3):559-69. PubMed ID: 1359461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo models of multiple system atrophy.
    Fernagut PO; Ghorayeb I; Diguet E; Tison F
    Mov Disord; 2005 Aug; 20 Suppl 12():S57-63. PubMed ID: 16092092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopaminergic neuronal degeneration and motor impairments following axon terminal lesion by instrastriatal 6-hydroxydopamine in the rat.
    Lee CS; Sauer H; Bjorklund A
    Neuroscience; 1996 Jun; 72(3):641-53. PubMed ID: 9157311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toward a primate model of L-dopa-unresponsive parkinsonism mimicking striatonigral degeneration.
    Ghorayeb I; Fernagut PO; Aubert I; Bezard E; Poewe W; Wenning GK; Tison F
    Mov Disord; 2000 May; 15(3):531-6. PubMed ID: 10830420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glial cell line-derived neurotrophic factor attenuates behavioural deficits and regulates nigrostriatal dopaminergic and peptidergic markers in 6-hydroxydopamine-lesioned adult rats: comparison of intraventricular and intranigral delivery.
    Lapchak PA; Miller PJ; Collins F; Jiao S
    Neuroscience; 1997 May; 78(1):61-72. PubMed ID: 9135089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.